
Mye-llennial Dilemma: What Are the Optimal Endpoints for Multiple Myeloma Clinical Trials?
Author(s) -
Shebli Atrash,
Saad Z. Usmani
Publication year - 2020
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v17.4.12884901897
Subject(s) - dilemma , multiple myeloma , clinical trial , medicine , philosophy , epistemology